ACTAVIS ACQUIRES HIGIA IN BULGARIA
Actavis Group, the international generic pharmaceuticals company agreed to acquire
Higia AD, one of the largest pharmaceutical distributors in Bulgaria, conditional
on certain conditions, including the approval of the Bulgarian Commission for
Protection of Competition, the Stock Exchange of Iceland announced today. The
acquisition price is confidential and the transaction will be financed through
a long-term credit facility.